Test Price
2,800 AED✅ Home Collection Available
SLC1A3 Gene Episodic Ataxia Type 6 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing
🚀 Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
📞 Clinical Guidance: Telephonic Post-Test Interpretation by DHA-Licensed Consultant Medical Genetics
💳 Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The SLC1A3 Episodic Ataxia Type 6 NGS Test analyzes the entire coding region of the SLC1A3 gene using next-generation sequencing to detect mutations causing this rare neurological disorder. This test is vital for confirming a clinical diagnosis, guiding treatment, and informing family members about their genetic risk.
| Feature | Our Test (NGS Sequencing) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Diagnostic Precision | >99.9% sensitivity & specificity for coding variants | Limited to known variants; may miss novel mutations |
| Methodology | Full gene NGS with CNV analysis | Sanger sequencing of selected exons |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (often requires follow‑up) |
| Clinical Reports | Integrated interpretation with ACMG classification | Manual interpretation; may lack CNV detection |
| Sample Types | Whole Blood, Extracted DNA, or Dried Blood Spot on FTA Card | Typically blood only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) states:
“Understanding neurological symptoms can be challenging. This genetic test provides precise confirmation of episodic ataxia type 6, but results must always be integrated with your full clinical presentation. Please continue all prescribed therapies unless explicitly adjusted by your treating neurologist.”
Medication Advisory
⚠️ Do not discontinue, alter, or adjust any prescribed medication without explicit approval from your doctor. Abrupt changes may worsen neurological symptoms or lead to adverse events.
Exclusion Criteria & Red Flags
- Exclusions: Active bleeding disorder contraindicating venipuncture. Alternative DNA sources (e.g., buccal swab) can be arranged after clinical review.
- Red Flags – Seek Immediate Medical Attention: Sudden severe ataxia with loss of consciousness, difficulty breathing, chest pain, or new‑onset confusion. This test is not intended for acute emergencies.
- Pre‑requirement: A mandatory genetic counselling session to document a pedigree of affected family members; clinical history must be provided.
Patient FAQ & Clinical Guidance
1. What is the SLC1A3 gene and how does it relate to episodic ataxia type 6?
The SLC1A3 gene provides instructions for a protein called EAAT1 that clears glutamate from synapses. Mutations disrupt this function, leading to episodic ataxia type 6 with recurrent balance and coordination difficulties.
2. How is the sample collected and what is the turnaround time?
A VIP mobile phlebotomist collects whole blood, extracted DNA, or a dried blood spot on an FTA card via temperature‑controlled cold chain. Results are delivered within 3–4 weeks with a comprehensive clinical report.
3. Are these genetic results confidential and does insurance cover the cost?
All genetic data is protected under UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Insurance coverage can be verified instantly via WhatsApp before sample collection.
UAE Regulatory & Data Privacy Adherence
This diagnostic service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow the provisions of Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information is stored securely and never shared without explicit consent.
Clinical & Logistical Metadata
| Test Name | SLC1A3 Gene Episodic Ataxia Type 6 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or Dried Blood Spot on FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Analysis |
| ICD-10-CM Code | G11.8 |
| LOINC Code | 94075-0 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians